A large U.S. randomized trial published in the New England Journal of Medicine found that etomidate, compared with ketamine, ...
VIENNA — Tirzepatide was associated with improvements in body weight and body composition, and with lower insulin doses, in the first-ever randomized controlled trial (RCT) of the drug in people with ...
Pfizer Inc ($PFE) announced an update on their ongoing clinical study. Study Overview: Pfizer (PFE) is running a Phase 2 study titled “AN ...
TipRanks on MSN
Regeneron advances phase 3 antibody trial in birch pollen eye allergy: What investors should know
Regeneron Pharmaceuticals ($REGN) announced an update on their ongoing clinical study. Study OverviewRegeneron Pharmaceuticals has launched a new ...
Elsewhere, Natera, Inc. (NASDAQ:NTRA), along with Quantum Leap Healthcare Collaborative, announced about publication of new ...
The European Randomized Study of Screening for Prostate Cancer (ERSPC) was initiated in 1993 to assess the effect of prostate-specific antigen (PSA) testing on prostate cancer mortality. Because ...
This pivotal Phase III trial is designed to evaluate the efficacy and safety of Debio 4126, a novel long-acting octreotide formulation and the first potential 3-month somatostatin analogue (SSA), in ...
A phase Ib study to assess the safety and efficacy of autologous tumor infiltrating lymphocytes (lifileucel) with adjuvant pembrolizumab (PEMBRO) for treatment of immunotherapy naïve patients with ...
A final discussion point is real-world applicability. Although PHAROS presents exceptional PFS, the modest difference between PFS and OS suggests that resistance remains a major hurdle. As with other ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback